CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Pyonteck, Stephanie M, Akkari, Leila, Schuhmacher, Alberto J, Bowman, Robert L, Sevenich, Lisa, Quail, Daniela F, Olson, Oakley C, Quick, Marsha L +12 more·2013·Nature Medicine

Cited by (1,005)

Items 901–1,000 of 1,005

  1. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma
    Yujie Huang, Prajwal Rajappa, Wenhuo Hu, Caitlin E. Hoffman, Babacar Cisse, Joon Hyung Kim, Emilie Gorge, Rachel N. Yanowitch, William Cope, Emma D. Vartanian et al. · 2017 · Journal of Clinical Investigation
  2. C olony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes
    Matthew W. Webb, Jianping Sun, Michael Allen Sheard, Wei‐Yao Liu, Hongwei Wu, Jeremy R. Jackson, Jemily Malvar, Richard Sposto, Dylan Daniel, Robert C. Seeger · 2018 · International Journal of Cancer
  3. CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis
    Michał Beffinger, Paulino Tallón de Lara, Sònia Tugues, Marijne Vermeer, Yannick Montagnolo, Isabel Ohs, Virginia Cecconi, Giulia Lucchiari, Aron Gagliardi, Nikola Misljencevic et al. · 2018 · JCI Insight
  4. Macrophage polarization as a novel weapon in conditioning tumor microenvironment for bladder cancer: can we turn demons into gods?
    Carolina Rubio, Ester Munera-Maravilla, Iris Lodewijk, Cristian Suárez-Cabrera, Viktoriya Karaivanova, Raquel Ruiz-Palomares, Jesús María Paramio, Marta Dueñas · 2018 · Clinical & Translational Oncology
  5. Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme
    Ramesh Duwa, Fakhrossadat Emami, Sooyeun Lee, Jee‐Heon Jeong, Simmyung Yook · 2019 · Journal of Industrial and Engineering Chemistry
  6. Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer
    Yan Deng, Jia-chun Hu, Shuhua He, Bin Lou, Tingbo Ding, Jintong Yang, Mingguang Mo, De-yong Ye, Lu Zhou, Xian‐Cheng Jiang et al. · 2020 · Acta Pharmacologica Sinica
  7. CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation
    Daniel Hwang, Maryamsadat Seyedsadr, Larissa Lumi Watanabe Ishikawa, Alexandra Boehm, Ziver Sahin, Giacomo Casella, Soohwa Jang, Michael V. Gonzalez, James P. Garifallou, Hakon H. Hakonarson et al. · 2022 · Proceedings of the National Academy of Sciences
  8. Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression
    Chenfei Lu, Tao Kang, Junxia Zhang, Kailin Yang, Yang Liu, Kefan Song, Qiankun Lin, Deobrat Dixit, Ryan C. Gimple, Qian Zhang et al. · 2025 · Nature Communications
  9. Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy
    Ekaterina A. Ivanova, Alexander Nikolaevich Orekhov · 2016 · Journal of Immunology Research
  10. Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
    Mario Orozco‐Morales, Giovanny Soca‐Chafre, Pedro Barrios‐Bernal, Norma Hernández‐Pedro, Oscar G. Arrieta · 2016 · Mediators of Inflammation
  11. Rescue of cognitive function following fractionated brain irradiation in a novel preclinical glioma model
    Xi Feng, Sharon Liu, David Chen, Susanna Rosi, Nalin M. Gupta · 2018 · eLife
  12. Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features
    Takuichiro Hide, Ichiyo Shibahara, Toshihiro Kumabe · 2019 · Brain Tumor Pathology
  13. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection
    Matthias B. Schneider, Anna‐Laura Potthoff, Vera C. Keil, Ági Güresir, Johannes M Weller, Valeri Borger, Motaz Hamed, Andreas Waha, Hartmut Vatter, Erdem Güresir et al. · 2019 · Journal of Neuro-Oncology
  14. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization
    Fransisca Leonard, Louis T. Curtis, Ahmed Ragab Hamed, Carolyn Zhang, Eric P. Chau, Devon Sieving, Biana Godin, Hermann B. Frieboes · 2020 · Cancer Immunology Immunotherapy
  15. Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment
    Vitaliy Davidov, Garrett L. Jensen, Sunny Mai, Shu‐Hsia Chen, Ping‐Ying Pan · 2020 · Frontiers in Immunology
  16. Macrophage Regulation of Granulopoiesis and Neutrophil Functions
    Christian Schulz, Tobias Petzold, Hellen Cristina Ishikawa-Ankerhold · 2020 · Antioxidants and Redox Signaling
  17. Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
    Elena Tirrò, Michele Massimino, Chiara Romano, Federica Martorana, Maria Stella Pennisi, Stefania Stella, Giuliana Pavone, Sandra Di Gregorio, Adriana Puma, Cristina Tomarchio et al. · 2021 · Frontiers in Oncology
  18. Advances in siRNA delivery strategies for the treatment of MDR cancer
    Md Abdus Subhan, Sara Aly Attia, Vladimir P. Torchilin · 2021 · Life Sciences
  19. Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma
    Alexandra Foster, Shubhanchi Nigam, David S. Tatum, Itay Raphael, Jide Xu, Rajeev Kumar, Elizabeth Plakseychuk, Joseph D. Latoche, Sarah Vincze, Bo Li et al. · 2021 · EBioMedicine
  20. Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model
    Kun-Hung Lee, Wan-Ching Yen, Wen‐Hsing Lin, Peichen Wang, You-Liang Lai, Yu‐Chieh Su, Chunyu Chang, Cai-Syuan Wu, Yuchen Huang, Chen-Ming Yang et al. · 2021 · Journal of Medicinal Chemistry
  21. Regulation of microglial survival and proliferation in health and diseases
    Ulland, Tyler K., Wang, Yaming, Colonna, Marco · 2015 · Seminars in Immunology
  22. Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580
    Valentina Fermi, Rolf Warta, Amélie Wöllner, Catharina Lotsch, Lena Jassowicz, Carmen Rapp, Maximilian Knoll, Gerhard Jungwirth, Christine Jungk, Philip Dao Trong et al. · 2023 · Clinical Cancer Research
  23. Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management
    Hanxiao Liu, Hui Lv, Xuehui Duan, Yan Du, Yixuan Tang, Wei Xu · 2023 · International Journal of Nanomedicine
  24. Engineered Microchannel Scaffolds with Instructive Niches Reinforce Endogenous Bone Regeneration by Regulating CSF‐1/CSF‐1R Pathway
    Xing Li, Yaling Cheng, Peiyang Gu, Chengkun Zhao, Zhulian Li, Lei Tong, Weinan Zeng, Jie Liang, En Luo, Qing Yan Jiang et al. · 2024 · Advanced Materials
  25. Macrophages: Targets for next-generation cancer immunotherapy
    Xiaoqi Sun, Matthew D. Park, Miriam Mérad, Brian D. Brown · 2026 · Cancer Cell
  26. State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer
    Whitney A. Spannuth Graybill, Anil K. Sood, Bradley J. Monk, Robert Louis Coleman · 2015 · Gynecologic Oncology
  27. Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation
    Muly Tham, Kar Wai Tan, Jo Keeble, Xiaojie Wang, Sandra Hubert, Luke Barron, Nguan Soon Tan, Masashi Kato, Armelle Prévost‐Blondel, Véronique Angeli et al. · 2014 · Oncotarget
  28. Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAFV600E melanoma
    Shin Foong Ngiow, Katrina M. Meeth, Kimberley A. Stannard, Deborah Sim Barkauskas, Gideon E. Bollag, Marcus Bosenberg, Mark John Smyth · 2015 · OncoImmunology
  29. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells
    Tamara Ius, Yari Ciani, Maria Elisabetta Ruaro, Miriam Isola, Marisa Sorrentino, Michela Bulfoni, Veronica Candotti, Cecilia Correcig, Evgenia Bourkoula, Ivana Manini et al. · 2017 · Neuro-Oncology
  30. Translational models of tumor angiogenesis: A nexus of in silico and in vitro models
    Shirin Soleimani, Milad Shamsi, Mehran Akbarpour Ghazani, Hassan Pezeshgi Modarres, Karolina Papera Valente, Mohsen Saghafian, Mehdi Mohammadi Ashani, Mohsen Akbari, Amir Sanati‐Nezhad · 2018 · Biotechnology Advances
  31. 6-Gingerol as an arginase inhibitor prevents urethane-induced lung carcinogenesis by reprogramming tumor supporting M2 macrophages to M1 phenotype
    Jingjing Yao, Zhenhua Du, Zibo Li, Shuhui Zhang, Yukun Lin, Haiyun Li, Lin Zhou, Yuehua Wang, Guixi Yan, Xianchuang Wu et al. · 2018 · Food & Function
  32. Synthesis and Initial In Vivo Evaluation of [11C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R)
    Sean S. Tanzey, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip S. Sherman, Peter J. H. Scott, Andrew V. Mossine · 2018 · Pharmaceuticals
  33. The Multifarious Role of Microglia in Brain Metastasis
    Manuel Sarmiento Soto, Nicola R. Sibson · 2018 · Frontiers in Cellular Neuroscience
  34. Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy
    Yeling Mei, Ruibo Wang, Wei Jiang, Bo Yang, Tengfei Zhang, Junlin Yu, Ming Huei Cheng, Yunzi Wu, Jianjun Cheng, Wang Ma · 2019 · Biomaterials Science
  35. Autophagy inhibition induces the repolarisation of tumour-associated macrophages and enhances chemosensitivity of laryngeal cancer cells to cisplatin in mice
    Ying Guo, Yufang Feng, Xinhua Cui, Qirong Wang, Xinliang Pan · 2019 · Cancer Immunology Immunotherapy
  36. Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM)
    Kianush Karimian Jazi, Philipp Münch, Allen A. Alexander, Manuel Dominik Fischer, Kira Pfleiderer, Manuel Piechutta, Matthia A. Karreman, Gergely Morten Solecki, Anna Sophie Berghoff, Mirco Friedrich et al. · 2020 · Theranostics
  37. Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma
    Kevin Liaw, Rajasekhar R. Ramireddy, Anjali Sharma, Jiangyu Li, Michelle Chang, Rishi B. Sharma, Sebastián Salazar, Sujatha Kannan, Rangaramanujam M. Kannan · 2020 · Bioengineering & Translational Medicine
  38. Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma
    Tanja Eisemann, Robert J. Wechsler‐Reya · 2022 · Genes & Development
  39. Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Jong Chul Park, Hari N. Krishnakumar, Srinivas Vinod Saladi · 2022 · Current Oncology
  40. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
    Christopher Chang, Velina S. Chavarro, Jakob V. E. Gerstl, Sarah E. Blitz, Lennard Spanehl, Daniel Dubinski, Pablo Andres Valdes, L. Tran, Saksham Gupta, Luisa Esposito et al. · 2024 · International Journal of Molecular Sciences
  41. PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
    Fabien Chauveau, Alexandra Winkeler, Sylvie Chalon, Hervé Boutin, Guillaume Becker · 2024 · Molecular Psychiatry
  42. Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment
    Rebecca Rosberg, Karolina I. Smoląg, Jonas Sjölund, Elinn Johansson, Christina Bergelin, Julia Wahldén, Vasiliki Pantazopoulou, Crister P Ceberg, Kristian Pietras, Anna Marie Blom et al. · 2024 · JCI Insight
  43. Anti-CSF-1 treatment is effective to prevent carcinoma invasion induced by monocyte-derived cells but scarcely by microglia
    Eva Rietkötter, Annalen Bleckmann, Michaela Bayerlová, Kerstin Menck, Han‐Ning Chuang, Britta Wenske, Hila Doron, Neta Erez, Claudia Rebecca Binder, Uwe‐Karsten Hanisch et al. · 2015 · Oncotarget
  44. Therapeutically reeducating macrophages to treat GBM
    Christopher Garris, Mikaël J. Pittet · 2013 · Nature Medicine
  45. Microenvironmental Effects of Cell Death in Malignant Disease
    Christopher D. Gregory, Catriona A. Ford, Jorine J. L. P. Voss · 2016 · Advances in experimental medicine and biology
  46. Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype
    Hongliang Dong, Yueyao Yang, Chen‐Hui Gao, Hehe Sun, Hongmin Wang, Chao Hong, Jun Wang, Fang‐Yuan Gong, Xiao‐Ming Gao · 2020 · Journal for ImmunoTherapy of Cancer
  47. Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
    Minfeng Yang, In Young Oh, Arpan Mahanty, Weilin Jin, Jung Sun Yoo · 2020 · Cancers
  48. Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation
    Yu‐Chih Chen, Yin‐Siew Lai, Yan-Der Hsuuw, Ko‐Tung Chang · 2021 · International Journal of Molecular Sciences
  49. The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations
    Maedeh Radandish, Parvin Khalilian, Nafiseh Esmaeil · 2021 · Frontiers in Immunology
  50. Spatial and Functional Heterogeneities Shape Collective Behavior of Tumor-Immune Networks
    Daniel K. Wells, Yishan Chuang, Louis M. Knapp, Dirk Brockmann, William L. Kath, Joshua N. Leonard · 2015 · PLoS Computational Biology
  51. Microglia and Brain Macrophages as Drivers of Glioma Progression
    Yuqi Zheng, Manuel B. Graeber · 2022 · International Journal of Molecular Sciences
  52. In vivo characterization and analysis of glioblastoma at different stages using multiscale photoacoustic molecular imaging
    Jinde Zhang, Xiang Ying Sun, Honghui Li, Haosong Ma, Fei Duan, Zhiyou Wu, Bowen Zhu, Ronghe Chen, Liming Nie · 2023 · Photoacoustics
  53. SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production
    Liyun Chen, Victoria Shi, Songyan Wang, Lulu Sun, Rebecca Freeman, Jasmine Yang, Matthew J. Inkman, Subhajit Ghosh, Fiona Ruiz, Kay Jayachandran et al. · 2023 · Journal of Clinical Investigation
  54. Metabolites and Immune Response in Tumor Microenvironments
    Salvatore Cortellino, Valter Daniel Longo · 2023 · Cancers
  55. Progress on the pathological tissue microenvironment barrier-modulated nanomedicine
    Han Han, Lei Xing, Bi‐Te Chen, Yang Liu, Tian‐Jiao Zhou, Yi Wang, Lingfeng Zhang, Ling Li, Chong‐Su Cho, Hu‐Lin Jiang · 2023 · Advanced Drug Delivery Reviews
  56. Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy
    Xiao-Feng Zheng, Ying Liu, Yiqiong Liu, Jie Zang, Kun Wang, Zichen Yang, Nana Chen, Jiuyuan Sun, Li Huang, Yan Li et al. · 2024 · Biomaterials
  57. Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF ‐ 1R
    David Guenoun, Nathan Blaise, Alexandre Sellam, Julie Roupret‐Serzec, Alice Jacquens, Juliette Van Steenwinckel, Pierre Gressèns, Cindy Bokobza · 2024 · Glia
  58. Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
    Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, Takuma Kato et al. · 2025 · JCI Insight
  59. Therapeutic Targeting of Tumor-associated Macrophages and Microglia in Glioblastoma
    Robert L. Bowman, Johanna A. Joyce · 2014 · Immunotherapy
  60. Macrophage Infiltration and Alternative Activation during Wound Healing Promote MEK1-Induced Skin Carcinogenesis
    Christine Weber, Stéphanie B. Telerman, Andreas S. Reimer, Inês Sequeira, Kifayathullah Liakath‐Ali, Esther N. Arwert, Fiona M. Watt · 2016 · Cancer Research
  61. Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma
    Noelyn Anne Hung, Ramona A. Eiholzer, Stenar Kirs, Jean Zhou, Kirsten A. Ward‐Hartstonge, Anna K. Wiles, Chris Miles Frampton, Ahmad J. Taha, Janice A. Royds, Tania L. Slatter · 2016 · Modern Pathology
  62. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas
    Ángel García de Lucas, Alberto J. Schuhmacher, Marta Oteo, Eduardo Romero, Juan A. Cámara, Alba De Martino, Alicia G. Arroyo, Miguel Ángel Morcillo, Massimo Squatrito, Jorge Luis Martinez-Torrecuadrada et al. · 2016 · PLoS ONE
  63. Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration
    Svenja Offer, Julien Albert Menard, Julio Enríquez Pérez, Kelin Gonçalves de Oliveira, Vineesh Indira Chandran, Maria C. Johansson, Anna Bång-Rudenstam, Peter Siesjö, Anna Ebbesson, Ingrid A. Hedenfalk et al. · 2019 · Journal of Experimental & Clinical Cancer Research
  64. Small-Molecule CSF1R Inhibitors as Anticancer Agents
    Qiuju Xun, Zhen Wang, Xianglong Hu, Ke Ding, Xiaoyun Lu · 2019 · Current Medicinal Chemistry
  65. Toward Normalization of the Tumor Microenvironment for Cancer Therapy
    Jie Zheng, Peng Gao · 2019 · Integrative Cancer Therapies
  66. Investigating Microglia in Health and Disease: Challenges and Opportunities
    Véronique E. Miron, Josef Priller · 2020 · Trends in Immunology
  67. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation
    Marta Chiavari, Gabriella Maria Pia Ciotti, Francesco Canonico, Fabio Altieri F., Pedro Miguel Lacal, Grazia Graziani, Pierluigi Navarra, Lucia Lisi · 2020 · International Journal of Molecular Sciences
  68. Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells
    Christina Pfirschke, Rapolas Žilionis, Camilla Engblom, Marius Messemaker, Angela E. Zou, Steffen Rickelt, Nicolas A. Gort-Freitas, Yunkang Lin, Ruben Bill, Marie Siwicki et al. · 2021 · Cancer Immunology Research
  69. Interleukin-1 Is Overexpressed in Injured Muscles Following Spinal Cord Injury and Promotes Neurogenic Heterotopic Ossification
    Hsu‐Wen Tseng, Irina Kulina, Dorothée Girard, Jules Gueguen, Cédryck Vaquette, Marjorie Salga, Whitney Fleming, Beulah Jose, Susan Marie Millard, Allison Robyn Pettit et al. · 2020 · Journal of Bone and Mineral Research
  70. Manipulating Macrophage/Microglia Polarization to Treat Glioblastoma or Multiple Sclerosis
    Thomas Kuntzel, Dominique Bagnard · 2022 · Pharmaceutics
  71. Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer
    Tuğba Akın Telli, Giacomo Bregni, Michele Vanhooren, Rita Saúde-Conde, Alain Hendlisz, Francesco Sclafani · 2022 · Cancer Treatment Reviews
  72. The role of tumor-associated macrophages in oral squamous cell carcinoma
    Yiwen Xue, Xiao Jie Song, Siyu Fan, Runzhi Deng · 2022 · Frontiers in Physiology
  73. Macrophage depletion blocks congenital SARM1-dependent neuropathy
    Caitlin B. Dingwall, Amy M. Strickland, Sabrina W. Yum, Aldrin Kay‐Yuen Yim, Jian Zhu, Peter L. Wang, Yurie Yamada, Robert E. Schmidt, Yo Sasaki, A. Joseph Bloom et al. · 2022 · Journal of Clinical Investigation
  74. Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment
    Naji Kharouf, Thomas Wayne Flanagan, Sofie-Yasmin Hassan, Hosam Shalaby, Marla Khabaz, Sarah-Lilly Hassan, Mosaad Megahed, Youssef Haïkel, Simeon Santourlidis, Mohamed Hassan · 2023 · Cancers
  75. Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
    Yancheng Lai, Xiaole Lu, Yankai Liao, Pei Ouyang, Hai Wang, Xian Zhang, Guanglong Huang, Songtao Qi, Yaomin Li · 2023 · Genes & Diseases
  76. Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages
    Nianci Zhu, Sijia Chen, Yu Jin, Meng Wang, Luyao Fang, Lingjing Xue, Dexiang Hua, Ziyao Zhang, Meng Jia, Meixi Hao et al. · 2024 · ACS Nano
  77. Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model
    Konrad R. Gabrusiewicz, Mohammad Belayat Hossain, Nahir Cortes‐Santiago, Xuejun Fan, Bozena Kaminska, Frank C. Marini, Juan Fueyo-Margareto, Candelaria Gomez‐Manzano · 2015 · Neoplasia
  78. The delicate balance of macrophages in colorectal cancer; their role in tumour development and therapeutic potential
    Rens Braster, Marijn Bögels, Robert H.J. Beelen, Marjolein van Egmond · 2015 · Immunobiology
  79. Personalized Medicine for Gliomas
    EricC Holland, Chibawanye Ene · 2015 · Surgical Neurology International
  80. CSF-1R Signaling in Health and Disease: A Focus on the Mammary Gland
    Amy R. Dwyer, Fiona J. Pixley · 2014 · Journal of Mammary Gland Biology and Neoplasia
  81. Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
    Brian J. Ahn, Ian Pollack, Hideho Okada · 2013 · Cancers
  82. Prioritization schema for immunotherapy clinical trials in glioblastoma
    Tiffany R. Hodges, Sherise Desiree Ferguson, Hillary G. Caruso, Gary Kohanbash, Shouhao Zhou, Timothy Francis Cloughesy, Mitchel Stuart Berger, George H. Poste, Mustafa Khasraw, Sujuan Ba et al. · 2016 · OncoImmunology
  83. Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer
    Zhaoxu Fang, Chengwen Wen, Xiaolan Chen, Rongping Yin, Chenglin Zhang, Xiaohua Wang, Yuhui Huang · 2017 · Oncotarget
  84. KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production
    Ran Chen, Chanel Keoni, Christopher A. Waker, Robert M. Lober, Yi-Hsien Chen, David H. Gutmann · 2018 · Neoplasia
  85. The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
    Sascha Marx, Yong Xiao, Marcel Baschin, Maximilian Splittstöhser, Robert Altmann, Eileen Moritz, Gabriele Jedlitschky, Sandra Bien-Möller, Henry W. S. Schroeder, Bernhard Hermann Rauch · 2019 · Cancers
  86. Pharmacological targeting of the tumor–immune symbiosis in glioblastoma
    Pang, Lizhi, Khan, Fatima, Dunterman, Madeline, Chen, Peiwen · 2022 · Trends in Pharmacological Sciences
  87. Spatial and molecular profiling of the mononuclear phagocyte network in Classic Hodgkin lymphoma
    Benjamin J. Stewart, Martin Fergie, Matthew D. Young, Claire Jones, Ashwin Sachdeva, Alex E. Blain, Chris M. Bacon, Vikki Rand, John Robert Ferdinand, Kylie Renee James et al. · 2023 · Blood
  88. Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis
    Zixiao Wang, Zihao Liu, Shan Wang, Xin Bing, Xiaoshuai Ji, Dong He, Min Han, Yanbang Wei, Chanyue Wang, Xia Qian et al. · 2023 · Asian Journal of Pharmaceutical Sciences
  89. ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype
    Naveen Sharma, Xiaozhou Fan, Oluwatomisin T. Atolagbe, Zhongqi Ge, K. Dao, Padmanee Sharma, James Patrick Allison · 2024 · The Journal of Experimental Medicine
  90. Embryonic Stem Cells Promoting Macrophage Survival and Function are Crucial for Teratoma Development
    Tianxiang Chen, Xi Wang, Lei Ming Guo, Mingmei Wu, Zhaoxia Duan, Jing Lv, Wenjiao Tai, Hemamalini Renganathan, Ruth Didier, Jinhua Li et al. · 2014 · Frontiers in Immunology
  91. Nanomedicine and cancer immunotherapy – targeting immunosuppressive cells
    Fernando Torres Andón, Marı́a José Alonso · 2015 · Journal of drug targeting
  92. Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages
    Dörthe Masemann, Katharina Köther, Meike Kuhlencord, Georg Varga, Johannes Roth, Brian Dennis Lichty, Ulf Rüdiger Rapp, Viktor Wixler, Stephan Ludwig · 2018 · OncoImmunology
  93. Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas
    Michael D. Caponegro, Richard A. Moffitt, Stella E. Tsirka · 2018 · Oncotarget
  94. High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination
    Annekatrin Arlt, Frederike von Bonin, Thorsten Rehberg, Paula Pérez-Rubio, Julia C. Engelmann, Katharina Limm, Sarah Reinke, Christian Dullin, Xueni Sun, Rieke Specht et al. · 2019 · Molecular Oncology
  95. Effect and Molecular Mechanisms of Traditional Chinese Medicine on Tumor Targeting Tumor-Associated Macrophages
    Jing He, Peihao Yin, Ke Xu · 2020 · Drug Design Development and Therapy
  96. Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
    Tsubasa Miyazaki, Eiichi Ishikawa, Narushi Sugii, Masahide Matsuda · 2020 · Cancers
  97. Incorporating Tumor-Associated Macrophages into Engineered Models of Glioma
    Erin A. Akins, Manish Kumar Aghi, Sanjay Kumar · 2020 · iScience
  98. Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
    Cristiana Tănase, Ana‐Maria Enciu, Elena Codrici, Ionela Daniela Popescu, Maria Dudău, Ana-Maria Dobri, Sevinci Pop, Simona Mihai, Ancuța-Augustina Gheorghișan-Gălățeanu, Mihail Eugen Hinescu · 2022 · International Journal of Molecular Sciences
  99. Myeloid Cells as Targets for Therapy in Solid Tumors
    Tiziana Cotechini, Terry R. Medler, Lisa M. Coussens · 2015 · The Cancer Journal
  100. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages
    Xi Li, Yu Fu, Bin Yang, Ensong Guo, Yifan Wu, Jia Ming Huang, Xiaoxiao Zhang, Rourou Xiao, Kezhen Li, Beibei Wang et al. · 2020 · Frontiers in Immunology